Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS

The role of damage-induced non coding RNA in the control of DNA damage response activation at telomeres in aging

Project description

Mechanistic insight into telomere dysfunction during ageing

Telomeres are repetitive nucleotide sequences located at the end of the chromosomes and have a protective role for chromosomal integrity during replication. However, telomeres progressively shorten at each cycle of cell division, and when they reach a certain length, they activate the DNA damage response (DDR) pathway. The EU-funded TeloRNAging project focuses on the mechanism of activation of the DDR pathway in dysfunctional telomeres as a contributor to ageing. Researchers will investigate the role of proteins and non-coding RNAs in DDR activation and test antisense oligonucleotides as inhibitors of the process. Results will provide important insight into the complex and poorly understood biological phenomenon of ageing.

Objective

Genome instability is a hallmark of cellular and organismal aging. Cells evolved a prompt set of actions known as the DNA damage response (DDR) to preserve genome integrity. Until very recently, DDR pathways have been studied as networks of interacting proteins only. We discovered that the full activation of the DDR pathways depends also on long and short damage-induced non coding RNA synthesised from exposed DNA ends of DNA double-strand breaks (DSB). Inhibitory antisense oligonucleotides (ASO) targeting such non coding RNAs in a sequence-specific manner prevent DDR activation at individual genomic sites. Telomeres, the ends of linear chromosomes, are the best characterized genomic sites of preferential DDR activation during aging. Also telomere dysfunction, similarly to DSB, triggers the synthesis of non coding RNA and ASO against them prevent DDR activation at dysfunctional telomeres in cultured cells and in mice. We plan to determine the mechanisms that unleash ncRNA biogenesis upon telomere dysfunction and identify their mechanisms of action in DDR activation. By exploiting our unprecedented ability to inhibit DDR selectively at telomeres, we will determine the specific contribution of telomeric DDR activation to the detrimental phenotypes associated with aging-related disorders.

Host institution

IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS
Net EU contribution
€ 2 497 500,00
Address
VIA ADAMELLO 16
20139 Milano
Italy

See on map

Region
Nord-Ovest Lombardia Milano
Activity type
Research Organisations
Links
Total cost
€ 2 497 500,00

Beneficiaries (1)